drugset
drugset / Trial / NCT02379637

Study to Evaluate the Efficacy of N-acetylcysteine (NAC) in the Treatment of the Common Cold and Cough

NCT02379637 ↗

Phase 2 Completed 70 enrolled Novartis
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is designed to improve knowledge regarding the initial effectiveness of N-acetylcysteine (NAC) on cold and cough symptoms.

Timeline

Start
2015-01
Primary completion
2015-04
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetylcysteine Small molecule — —

Indications

common cold